Helen Lee

Inventor

Add to Portfolio

Stats

Details

Work History

Patent OwnerApplications FiledYear
IPSEN BIOPHARM LTD.
1
2016
GOTECH INTERNATIONAL LIMITED
1
2015
Warner-Lambert Company
1
2003
DIAGNOSTICS FOR THE REAL WORLD, LTD.
6
5
1
3
2
2
2
2001
2003
2004
2007
2008
2011
2013
MEDTRONIC MINIMED, INC.
2
2006
MERRIMACK PHARMACEUTICALS, INC.
2
1
1
2013
2014
2016
WEIGHT WATCHERS INTERNATIONAL, INC.
1
2013
Genaissance Pharmaceuticals, Inc.
2
2001

Inventor Addresses

AddressDuration
Ann Arbor, MIApr 06, 04 - Apr 06, 04
Arlington, MA, USMar 22, 18 - Oct 31, 24
BOSTON, MA, USApr 27, 17 - Apr 27, 17
Boston, MA, USApr 02, 15 - May 15, 18
Brooklyn, NY, USMay 29, 14 - May 29, 14
CAMBRIDGE, MA, USOct 20, 16 - Oct 20, 16
Cambridge, GBJan 22, 04 - Dec 13, 18
Cambridge, MA, USFeb 23, 17 - Jan 05, 23
Newport Beach, CA, USOct 01, 15 - Oct 18, 18
San Gabriel, CAJul 26, 07 - Jul 26, 07
San Gabriel, CA, USJul 26, 11 - Jul 26, 11
Shelton, CTFeb 18, 03 - Feb 18, 03
Shelton, CT, USDec 05, 02 - Dec 05, 02

Technology Profile

Technology Matters
A61K: PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 11
A61P: THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 3
A63F: CARD, BOARD, OR ROULETTE GAMES; INDOOR GAMES USING SMALL MOVING PLAYING BODIES; GAMES NOT OTHERWISE PROVIDED FOR 1

See more…

Patents / Publication

Patents / Publication #Year of Publication / IssuedTitleCitations
2024/0358,7062024Methods for Treating Metastatic Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan and Oxaliplatin0
2023/0062,4252023Methods for Treating Metastatic Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan and Oxaliplatin0
2023/0000,8582023Nanoliposomal Irinotecan for Use in Treating Small Cell Lung Cancer0
113445522022Methods for treating metastatic pancreatic cancer using combination therapies comprising liposomal irinotecan and oxaliplatin2
113181312022Nanoliposomal irinotecan for use in treating small cell lung cancer2

See more…


We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
> Upgrade to our Level for up to -1 portfolios!.